EarningsORIONPHARM
ORIONPHARM Earnings Update
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 17 November 2024. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Q1 Un-audited): Consolidated EPS was Tk. 0.24 for July-September 2024 as against Tk. 0.76 for July-September 2023; Consolidated NOCFPS was Tk. 1.85 for July-September 2024 as against Tk. 3.89 for July-September 2023. Consolidated NAV per share was Tk. 89.88 (including revaluation surplus) as on September 30, 2024 and Tk. 92.05 as on June 30, 2024. Consolidated NAV per share was Tk. 82.11 (excluding revaluation surplus) as on September 30, 2024 and Tk. 84.27 as on June 30, 2024. (cont.)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6739689c9f31fb035ffe50d2
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.